Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of PLX8394 as a Single Agent in Patients With Advanced Unresectable Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02428712
Recruitment Status : Recruiting
First Posted : April 29, 2015
Last Update Posted : July 1, 2021
Sponsor:
Information provided by (Responsible Party):
Fore Biotherapeutics

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : February 2022
Estimated Study Completion Date : June 2022